Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
US Army
Cerilliant
Federal Trade Commission
Dow
Colorcon
Daiichi Sankyo
Fish and Richardson
Chinese Patent Office

Generated: November 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020803

« Back to Dashboard

NDA 020803 describes ALREX, which is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from one supplier. Additional details are available on the ALREX profile page.

The generic ingredient in ALREX is loteprednol etabonate. There are ten drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
Summary for 020803
Tradename:ALREX
Applicant:Bausch And Lomb
Ingredient:loteprednol etabonate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020803
Mechanism of ActionCorticosteroid Hormone Receptor Agonists
Medical Subject Heading (MeSH) Categories for 020803
Anti-Allergic Agents
Suppliers and Packaging for NDA: 020803
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALREX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020803 NDA Bausch & Lomb Incorporated 24208-353 24208-353-01 1 BOTTLE, DROPPER in 1 CARTON (24208-353-01) > 1 mL in 1 BOTTLE, DROPPER
ALREX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020803 NDA Bausch & Lomb Incorporated 24208-353 24208-353-05 1 BOTTLE, DROPPER in 1 CARTON (24208-353-05) > 5 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION/DROPS;OPHTHALMICStrength0.2%
Approval Date:Mar 9, 1998TE:RLD:Yes

Expired US Patents for NDA 020803

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch And Lomb ALREX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020803-001 Mar 9, 1998 ➤ Sign Up ➤ Sign Up
Bausch And Lomb ALREX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020803-001 Mar 9, 1998 ➤ Sign Up ➤ Sign Up
Bausch And Lomb ALREX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020803-001 Mar 9, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Queensland Health
McKinsey
Federal Trade Commission
Dow
Merck
Accenture
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: